ATYR (aTyr Pharma Inc) Net Profit

ATYR (aTyr Pharma) - company brandmark

aTyr Pharma, Inc. (ATYR) integrates ESG principles into the development of immune drugs, ensuring strict biosafety controls. The tRNA therapy ecosystem for sarcoidosis, supported by the FDA, is building a loyal patient base. High expenditures on cold chain transportation guarantee the integrity of the medications. The company's profit trajectory demonstrates operational efficiency, where the final indicator value reaches -0.06.

ATYR (aTyr Pharma, Inc.) Net Profit history from 06/06/2024 to 10/30/2026

Analytical breakdowns and data insights for company aTyr Pharma (ATYR)

- price and consensus price forecast:
Stock Quotes aTyr Pharmaceuticals|ATYR - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization aTyr Pharmaceuticals|ATYR - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share aTyr Pharma|ATYR - Book Capitalization|Market Capitalization to Book Value atyrpharma.com|ATYR - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio aTyr Pharma, Inc.|ATYR - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio aTyr Pharma Inc|ATYR - Company Total Debt|Debts to Book Capitalization aTyr Pharmaceuticals|ATYR - Company Long-Term Debt|Company Short-Term Indebtedness aTyr Pharma|Immediate Liquidity atyrpharma.com
- net income and valuation multiples indicators:
ATYR - Net Profit
Summary company analysis:aTyr Pharma, Inc.
Core merchandise of aTyr

Developing drugs for rare pulmonary pathologies requires colossal expenditures on clinical trials, which directly determines the cash flow dynamics of aTyr Pharma, Inc. (ATYR). The company's net operating profit is calculated as the final remaining funds after deducting all operating expenses from revenue, reflecting the business's actual ability to adapt to market conditions and ensure the project's financial stability.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|PHAR - Net Profit|NKTR (Nektar Therapeutics) - Net Income|UPB: Profit After Payment of Taxes|Net Income ZBIO|Company Net Income Immunome Inc IMNM|Company Net Income Gossamer Corp (GOSS)|KALV (KalVista Corp) - Final Profit|Septerna Inc - Net Income|Final Profit PVLA|SVRA - Company Net Income|Profit After Tax RIGL|ANAB: Net Profit|Astria Corp - Final Profit|ENGN (enGene Holdings Inc.) - Net Profit|Net Profit rapt.com|Company Net Income Aerovate Therapeutics Inc (JBIO)|ACRS (Aclaris Therapeutics Inc.) - Final Profit|Company Net Income Kyverna KYTX|TLSA - Net Income|Cabaletta Bio, Inc. - Net Profit|VTYX - Net Profit|THTX (Theratechnologies) - Net Income|Avalo Therapeutics, Inc. - Final Profit|ELDN (Eledon) - Net Profit|Agenus, Inc (AGEN) - Net Financial Result|Company Net Income Climb Bio Inc (CLYM)|zurabio.com - Company Profit|Net Profit ADAG (Adagene Inc.)|IMA - Net Income|STTK: Net Income|Net Financial Result Equillium, Inc. EQ|CNTB: Net Profit|Immunic (IMUX) - Net Profit|Net Income ATRA|IFRX (InflaRx GmbH) - Profit After Payment of Taxes|Net Income XFOR (X4 Pharma)|ACET - Company Net Income|Company Net Income Celularity CELU|Final Profit INMB|BRNS - Company Net Income|Profit After Tax KZR|SABS: Net Profit|Akari Therapeutics, Plc - Final Profit|ENLV (Enlivex Therapeutics Ltd) - Net Profit|Net Profit Q32 Bio Corp|Company Net Income GeoVax (GOVX)|EDSA (Edesa Biotech Inc) - Final Profit|Company Net Income iBio Corp IBIO|CARM - Net Income|XTL Biopharmaceuticals - Net Profit|BOLT - Net Profit|HCWB (hcwbiologics.com) - Net Income|Aptevo Therapeutics Inc. - Final Profit|AIM (AIM ImmunoTech) - Net Profit|Aditxt Corp (ADTX) - Net Financial Result|Company Net Income GRI Bio, Inc. (GRI)|Net Income xortx.com XRTX|Company Net Income Vyome Holdings HIND|REVB - Net Income|INDP: Net Income|SCNI - Net Profit|calcimedica.com (CALI) - Company Net Income|Company Profit AFMD|ALLK (Allakos Inc) - Net Profit|Company Net Income HOOKIPA HOOK|Net Profit IGMS|Net Profit iTeos Pharma (ITOS)|Ocean Biomedical, Inc. - Net Income|Profit After Payment of Taxes TCBP (tcbiopharm.com)|THRD: Net Income